Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients.
Noise in multiple sclerosis: unwanted and necessary.
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis.
Mesenchymal stem cells: A new diagnostic tool?
Therapeutic potential of cannabinoid medicines.
Faith as a resource in patients with multiple sclerosis is associated with a positive interpretation of illness and experience of gratitude/awe.
JCV epidemiology in MS (JEMS)-Epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients-Portuguese data.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
Use of botulinum toxin for genitourinary conditions: What is the evidence?
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
PML: The Dark Side of Immunotherapy in Multiple Sclerosis.
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.
Genetic proof for the transient nature of the Th17 phenotype.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].

Pages